Financials
Financial year 2025
Worth noting
- Little cash and receivables against the short-term debts.
Gross margin
€ -91,977
▼ 177% vs 2024
Profit
Caution€ -621,245
▼ 1772% vs 2024
Debts
Low€ 662,480
▲ 13% vs 2024
ASTERION RESEARCH & DEVELOPMENT from Gent, company number BE0682704608, closed financial year 2025 with a result of € -621,245 after tax. For that financial year ASTERION RESEARCH & DEVELOPMENT recorded a gross margin of € -91,977 and equity of € 1.6 million. Compared with financial year 2024, the result moved from € 37,163 to € -621,245. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
What happened at ASTERION RESEARCH & DEVELOPMENT?
What happened at ASTERION RESEARCH & DEVELOPMENT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 621,245 (▼ 1772% vs 2024). Source: NBB ↗
- New establishment in Gent. KBO
- Jeroen Hofenk became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 32,228 profit in 2021 to € 621,245 loss in 2025.
Best year ever: 2022, with € 249,794 profit.
A new publication or filing at ASTERION RESEARCH & DEVELOPMENT? We notify you, reason included.
Follow ASTERION RESEARCH & DEVELOPMENTNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind ASTERION RESEARCH & DEVELOPMENT is Jeroen Hofenk. It owns 52.8% of Swiftpharma and 30% of Bombi Biomics itself.
Directors
According to the 2025 annual accounts
since 2017
Establishments
Establishment units
Physical locations of this company
Karel van de Woestijnestraat 6
9000 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Details
- Company number
- 0682.704.608
- VAT number
- BE 0682.704.608
- Registered office
- Karel van de Woestijnestraat 6, 9000 Gent
- Names & denominations
- ASTERION RESEARCH & DEVELOPMENT
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 October 2017
- Peppol
- Active · Active since 20 May 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Vervaardiging van farmaceutische grondstoffen